BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 9115786)

  • 21. How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study.
    Rafferty T; Wilson-Davis K; McGavock H
    BMJ; 1997 Jul; 315(7101):166-70. PubMed ID: 9251548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
    Nemlekar P; Shepherd M; Lawson K; Rush S
    J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of doctors' ethnicity and country of qualification on prescribing patterns in single handed general practices: linkage of information collected by questionnaire and from routine data.
    Gill PS; Dowell A; Harris CM
    BMJ; 1997 Dec; 315(7122):1590-4. PubMed ID: 9437279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of prescribing unit with index including both age and sex in assessing general practice prescribing costs.
    Purves IN; Edwards C
    BMJ; 1993 Feb; 306(6876):496-8. PubMed ID: 8448463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influences on prescribing in non-fundholding general practices.
    Eccles MP; Soutter J; Bateman DN; Campbell M; Smith JM
    Br J Gen Pract; 1996 May; 46(406):287-90. PubMed ID: 8762744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fundholders' prescribing costs: the first five years.
    Harris CM; Scrivener G
    BMJ; 1996 Dec; 313(7071):1531-4. PubMed ID: 8978232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting the uptake of new medicines in secondary care - a literature review.
    Chauhan D; Mason A
    J Clin Pharm Ther; 2008 Aug; 33(4):339-48. PubMed ID: 18613851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The UK indicative prescribing scheme: background and operation.
    Bligh J; Walley T
    Pharmacoeconomics; 1992 Aug; 2(2):137-52. PubMed ID: 10146953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.
    Sacks CA; Lee CC; Kesselheim AS; Avorn J
    JAMA; 2018 Aug; 320(7):650-656. PubMed ID: 30140875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring economic impact of applying daily average consumption limits.
    Flavin BM; Nishida LM; Karbowicz SH; Renner ME; Leonard RJ
    J Manag Care Pharm; 2014 Feb; 20(2):159-64. PubMed ID: 24456317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age, sex, and temporary resident originated prescribing units (ASTRO-PUs): new weightings for analysing prescribing of general practices in England.
    Roberts SJ; Harris CM
    BMJ; 1993 Aug; 307(6902):485-8. PubMed ID: 8305014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of electronic prescribing on formulary compliance and generic drug utilization in the ambulatory care setting: a retrospective analysis of administrative claims data.
    Ross SM; Papshev D; Murphy EL; Sternberg DJ; Taylor J; Barg R
    J Manag Care Pharm; 2005 Jun; 11(5):410-5. PubMed ID: 15934800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.
    Patel RA; Walberg MP; Tong E; Tan F; Rummel AE; Woelfel JA; Carr-Lopez SM; Galal SM
    J Manag Care Spec Pharm; 2014 Mar; 20(3):283-90. PubMed ID: 24564812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of an interest in asthma on prescribing costs in general practice.
    Jones K
    Qual Health Care; 1992 Jun; 1(2):110-3. PubMed ID: 10136839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs.
    Bradlow J; Coulter A
    BMJ; 1993 Nov; 307(6913):1186-9. PubMed ID: 8251847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do GPs working in practice with high or low prescribing costs have different views on prescribing cost issues?
    Avery AJ; Wetzels RV; Rodgers S; O'Neill C
    Br J Gen Pract; 2000 Feb; 50(451):100-4. PubMed ID: 10750205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational prescribing in primary care (RaPP): economic evaluation of an intervention to improve professional practice.
    Fretheim A; Aaserud M; Oxman AD
    PLoS Med; 2006 Jun; 3(6):e216. PubMed ID: 16737349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influencing NSAID prescribing in primary care using different feedback strategies.
    Braybrook S; Walker R
    Pharm World Sci; 2000 Apr; 22(2):39-46. PubMed ID: 10849921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some patterns of prescribing by urban general practitioners.
    McGavock H
    Br Med J (Clin Res Ed); 1988 Mar; 296(6626):900-2. PubMed ID: 3129067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.